Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. 5+ years of industry or research experience building machine learning models on EHR data, including linked claims or other real-world data, with substantiated results: peer-reviewed publications, deployed models, or externally validated performance.